Promising Medical Stocks To Watch Now – March 25th

Walmart, Tenon Medical, Eli Lilly and Company, AbbVie, and Merck & Co., Inc. are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of companies that operate within the healthcare sector, including pharmaceutical firms, medical device manufacturers, and biotechnology companies. These stocks typically represent businesses involved in the research, development, production, or distribution of medical products and services, and they can be influenced by factors such as regulatory changes, technological advancements, and overall healthcare demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Walmart (WMT)

Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.

Shares of WMT traded down $2.31 on Tuesday, reaching $85.19. The stock had a trading volume of 13,440,671 shares, compared to its average volume of 15,959,564. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.23 and a current ratio of 0.82. The company has a 50-day simple moving average of $95.12 and a 200-day simple moving average of $89.19. The firm has a market capitalization of $682.92 billion, a price-to-earnings ratio of 35.35, a price-to-earnings-growth ratio of 4.42 and a beta of 0.53. Walmart has a 12-month low of $58.56 and a 12-month high of $105.30.

Tenon Medical (TNON)

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.

Shares of Tenon Medical stock traded up $2.86 during midday trading on Tuesday, hitting $3.84. The company had a trading volume of 247,361,987 shares, compared to its average volume of 972,604. Tenon Medical has a 52-week low of $0.91 and a 52-week high of $15.79. The company has a 50 day moving average of $1.44 and a 200 day moving average of $2.56. The stock has a market capitalization of $12.05 million, a P/E ratio of -0.15 and a beta of 1.89.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE LLY traded down $10.30 during midday trading on Tuesday, hitting $854.60. The stock had a trading volume of 1,044,602 shares, compared to its average volume of 3,149,249. The business’s 50 day moving average is $837.36 and its 200-day moving average is $837.97. Eli Lilly and Company has a 52 week low of $711.40 and a 52 week high of $972.53. The company has a quick ratio of 0.97, a current ratio of 1.15 and a debt-to-equity ratio of 2.00. The company has a market cap of $810.31 billion, a P/E ratio of 72.90, a PEG ratio of 1.40 and a beta of 0.34.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

NYSE ABBV traded down $6.90 during mid-day trading on Tuesday, reaching $202.27. The stock had a trading volume of 3,173,026 shares, compared to its average volume of 5,250,727. The stock has a market cap of $357.08 billion, a PE ratio of 84.38, a price-to-earnings-growth ratio of 1.62 and a beta of 0.61. AbbVie has a 1 year low of $153.58 and a 1 year high of $218.66. The company has a debt-to-equity ratio of 17.94, a current ratio of 0.66 and a quick ratio of 0.55. The company has a fifty day moving average price of $195.14 and a 200 day moving average price of $188.73.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of Merck & Co., Inc. stock traded down $3.93 on Tuesday, reaching $88.38. The company’s stock had a trading volume of 5,959,964 shares, compared to its average volume of 10,243,650. Merck & Co., Inc. has a 52 week low of $81.04 and a 52 week high of $134.63. The firm’s fifty day simple moving average is $92.83 and its two-hundred day simple moving average is $100.78. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79. The company has a market capitalization of $223.26 billion, a price-to-earnings ratio of 13.17, a P/E/G ratio of 0.77 and a beta of 0.35.